Physician profile
Rohit V Dadi
NPI 1861986838
$13,272.75
in general payments reported to CMS, 2019-2025
16 companies · $2,092 in 2025
The $2,092 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,992 · 2022: $3,508 · 2023: $1,743 · 2024: $1,937 · 2025: $2,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,509 · Food and Beverage: $2,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,509.00 |
| Food and Beverage | $2,263.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $4,219.41 | 2021-2025 | |
| Paragon 28, INC. | $2,242.52 | 2022-2025 | Mtp, Portfolio, Bun-Yo-Matic |
| Treace Medical Concepts, INC. | $1,902.52 | 2021-2025 | |
| Stryker Corporation | $1,517.07 | 2021-2025 | Augment Injectable, N/A |
| Nevro Corp. | $1,064.52 | 2022-2023 | Senza |
| Ossio INC | $573.95 | 2021 | |
| Anika Therapeutics, INC. | $447.96 | 2023 | Fna Products |
| Mimedx Group, INC. | $371.37 | 2024-2025 | |
| Organogenesis INC. | $250.00 | 2023-2024 | Novachor, Apligraf, Nushield |
| Arthrex, INC. | $230.26 | 2022-2023 | |
| Bone Support INC. | $146.48 | 2024 | Ceramentbone Void Filler, Cerament G |
| Wildwood Medical LLC | $126.53 | 2025 | |
| Curonix LLC | $115.83 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Pharmaceuticals Incorporated | $26.67 | 2023 | Iovera, Exparel |
| Heron Therapeutics, INC. | $19.85 | 2025 | Zynrelef |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17.81 | 2023 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Dadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.